U.S. market Open. Closes in 6 hours 4 minutes

MGRX | Mangoceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
Revenue731.49K8.94KN/A
Cost of Revenue299.99K4.09KN/A
Gross Profit431.50K4.85KN/A
Operating Expenses9.65M2.00M17.52K
Selling, General & Admin9.65M2.00M17.52K
Research & DevelopmentN/AN/AN/A
Other Operating Expenses6.47KN/AN/A
Operating Income-9.22M-1.99M-17.52K
Other Expenses / Income6.47K-6.47K-181.00
Before Tax Income-9.21M-2.00M-17.70K
Income Tax Expenses1.00-224.62K-70.08K
Net Income-9.21M-2.00M-17.70K
Interest ExpensesN/A6.47K181.00
Basic Shares Outstanding21.42M17.32M17.32M
Diluted Shares Outstanding21.42M17.32M17.32M
EBITDA-9.19M-1.99M-17.52K
EBITDA Margin-1,256.88%-22,236.48%0.00%
EBIT-9.21M-2.22M-87.60K
EBIT Margin-1,259.40%-24,792.53%0.00%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙